U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Madison Polymeric Engineering - 456082 - 10/26/2017
  1. Warning Letters

CLOSEOUT LETTER

Madison Polymeric Engineering MARCS-CMS 456082 —


Recipient:
Madison Polymeric Engineering

United States

Issuing Office:

United States


 

   

Black HHS-Blue FDA Logo

 

Office of Medical Devices and Radiological Health Operations (Division-1)
One Montvale Avenue
Stoneham, MA 02180 

 
 

DELIVERED VIA UPS

October 26, 2017

Walter L. Maguire, Jr.
President
Madison Polymeric Engineering
965 West Main Street
Branford, CT 06405

Dear Mr. Maguire:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter, CMS Case 456082, issued on April 22, 2015. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely yours,
/S/

Richard Cherry
Compliance Officer
Office of Medical Device & Radiological Health
Division-1 East
Office of Regulatory Affairs 

Back to Top